Inovio Pharmaceuticals is trading 10.94% higher at $1.12 in after-hours trading; a report grouped it with vaccine stocks jumping amid hantavirus-related news, a possible but unconfirmed catalyst.
- It closed at $1.01 on October 20; no company-specific announcement was identified that day. The latest listed company news was dated September 1.
- The October 30 FDA decision date for INO-3107 is upcoming context, not a new announcement.